Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Review of Neurotherapeutics|June 21, 2006
Biomarkers in Parkinson's diseaseE Ray Dorsey, Robert G Holloway, Bernard M RavinaPlos One|September 7, 2012
Biosignatures for Parkinson's disease and atypical parkinsonian disorders patientsJudith A Potashkin, Jose A Santiago, Bernard M Ravina, et al.Parkinsonism & Related Disorders|July 6, 2010
Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experienceJay S Schneider, Jordan J Elm, Sotirios A Parashos, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Neuroprotection trials in Parkinson's disease: systematic reviewRobert G Hart, Lesly A Pearce, Bernard M Ravina, et al.Nature Reviews. Drug Discovery|September 13, 2018
Gene therapy for neurological disorders: progress and prospectsBenjamin E Deverman, Bernard M Ravina, Krystof S Bankiewicz, et al.Nature Reviews. Drug Discovery|August 11, 2018
Gene therapy for neurological disorders: progress and prospectsBenjamin E Deverman, Bernard M Ravina, Krystof S Bankiewicz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2014
Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's diseaseFrançoise J Siepel, Kolbjørn S Brønnick, Jan Booij, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2011
Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker StudyHongliu Ding, Alison K Sarokhan, Sarah S Roderick, et al.Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.Pageof 1